ArticleMolecular and cellular biochemistry2021

Knockdown of RSAD2 attenuates B cell hyperactivity in patients with primary Sjögren's syndrome (pSS) via suppressing NF-κb signaling pathway.

Hong Zhu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.